Vitaco: Primavera, Shanghai Pharma buy Australia's Vitaco
Primavera Capital has teamed up with Shanghai Pharmaceuticals to buy Australia-listed nutrition and healthcare products company Vitaco for approximately A$313 million ($238 million).
Read full article »
CEO
Viitaco produces and distributes health foods, supplements and sports nutritional products.
Read more